Stock Rich List
#8690 on the rich list of 14,644 insiders

Troy E. Wilson

President and CEO at Kura Oncology; Director at Puma Biotechnology; Director at Atrium Therapeutics. Based in San Diego, California.

$10.1M
in disclosed stock, +$12K (+0.11%) today
Market closed. Prices as of Nov 19, 4:00 PM ET
Rank
8690th of 14,644
Companies held
3
Largest holding
KURA, 95.3% of total
Latest SEC filing
Nov 16, 2026
Listed but not counted
$2.2M

What the $10.1M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Kura Oncology KURA
Common Stock
Through One Fish Two Fish Revocable Trust679,194$7.35$5.0M49.2%Form 4/A, Nov 16, 2026
Kura Oncology KURA
Common Stock
Directly635,456$7.35$4.7M46.1%Form 4, Nov 16, 2026
Puma Biotechnology PBYI
Common Stock
Directly54,750$7.12$390K3.8%Form 4, Sep 14, 2026
Atrium Therapeutics RNA
Common Stock
Directly10,360$6.98$72K0.7%Form 3, Feb 26, 2026
Atrium Therapeutics RNA
Common Stock
Indirectly (see filing footnote)1,371$6.98$10K0.1%Form 3, Feb 26, 2026
Puma Biotechnology PBYI
Common Stock
Through Child #1400$7.12$3K0.0%Form 4, Sep 14, 2026
Puma Biotechnology PBYI
Common Stock
Through Child #2150$7.12$1K0.0%Form 4, Sep 14, 2026

Share counts are the amounts Troy E. Wilson reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Troy E. Wilson's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Kura Oncology KURA
Common Stock
Through Lorax Charitable Remainder Unitrust
Held for a foundation or charity
300,000$7.35$2.2M—Form 4/A, Nov 13, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 16, 2026BoughtKURA101,119$7.42$750KView
Nov 16, 2026BoughtKURA101,119$7.42$750KView
Nov 13, 2026BoughtKURA98,881$7.63$754KView
Nov 13, 2026BoughtKURA98,881$7.63$754KView
Sep 14, 2026SoldPBYI5,000$9.10$46KView
Aug 24, 2026BoughtKURA100,000$12.39$1.2MView
Aug 17, 2026BoughtKURA100,000$11.12$1.1MView
Jun 12, 2026SoldPBYI10,800$7.20$78KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
8687Chris Freeman
Chief Commercial Officer, Guardant Health. Palo Alto, CA
$10.1M+$31K (+0.31%)
8688Chad M. Holmes
EVP AND CHIEF CORP DEV OFFICER, CRA International. Boston, MA
$10.1M+$82K (+0.81%)
8689Kathleen Flaherty Burke
EVP, GC & Secretary, MKS. Andover, MA
$10.1M−$275K (−2.64%)
8690Troy E. Wilson
President and CEO, Kura Oncology. San Diego, CA
$10.1M+$12K (+0.11%)
8691Robert William Leibrock
Chief Financial Officer, ACI Worldwide. Elkhorn, NE
$10.1M−$480K (−4.52%)
8692Corina I. Cacovean
Chief Legal Officer, AppLovin. Palo Alto, CA
$10.1M−$318K (−3.04%)
8693Robert T. Webb
Director, National Health Investors. Murfreesboro, TN
$10.1M−$170K (−1.65%)

Other Kura Oncology insiders

All KURA insiders

Questions

How much stock does Troy E. Wilson own?

Troy E. Wilson holds $10,138,296 in listed stock based on SEC filings and current prices, mostly Kura Oncology (KURA). That ranks 8690th on the Stock Rich List.

Is this Troy E. Wilson's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Troy E. Wilson last buy or sell stock?

The most recent open-market trade on file is a purchase of 101,119 KURA shares on Nov 16, 2026 at $7.42.